Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 16 studies | 37% ± 16% | |
endothelial cell | 13 studies | 29% ± 16% | |
microglial cell | 13 studies | 50% ± 17% | |
fibroblast | 12 studies | 27% ± 8% | |
macrophage | 11 studies | 30% ± 16% | |
oligodendrocyte precursor cell | 9 studies | 34% ± 14% | |
plasma cell | 8 studies | 33% ± 11% | |
GABAergic neuron | 8 studies | 41% ± 22% | |
plasmacytoid dendritic cell | 8 studies | 27% ± 7% | |
adipocyte | 8 studies | 36% ± 12% | |
oligodendrocyte | 8 studies | 26% ± 10% | |
myeloid cell | 7 studies | 25% ± 6% | |
epithelial cell | 7 studies | 30% ± 12% | |
glutamatergic neuron | 6 studies | 44% ± 24% | |
interneuron | 6 studies | 41% ± 21% | |
dendritic cell | 6 studies | 21% ± 6% | |
smooth muscle cell | 6 studies | 25% ± 8% | |
type II pneumocyte | 6 studies | 29% ± 9% | |
hepatocyte | 5 studies | 52% ± 24% | |
neuron | 5 studies | 37% ± 22% | |
monocyte | 5 studies | 22% ± 4% | |
pericyte | 5 studies | 30% ± 12% | |
ciliated cell | 4 studies | 22% ± 3% | |
muscle cell | 4 studies | 26% ± 3% | |
type I pneumocyte | 4 studies | 23% ± 3% | |
club cell | 4 studies | 23% ± 5% | |
B cell | 3 studies | 22% ± 5% | |
non-classical monocyte | 3 studies | 21% ± 4% | |
plasmablast | 3 studies | 44% ± 11% | |
GABAergic interneuron | 3 studies | 29% ± 7% | |
glial cell | 3 studies | 33% ± 7% | |
granule cell | 3 studies | 20% ± 4% | |
pro-B cell | 3 studies | 26% ± 3% | |
retinal rod cell | 3 studies | 49% ± 12% | |
cholangiocyte | 3 studies | 39% ± 26% | |
abnormal cell | 3 studies | 36% ± 16% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 2% | |
basal cell | 3 studies | 40% ± 23% | |
goblet cell | 3 studies | 28% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 6144.48 | 180 / 180 | 99% | 36.71 | 427 / 430 |
lung | 99% | 4795.37 | 575 / 578 | 100% | 52.98 | 1152 / 1155 |
esophagus | 100% | 6885.95 | 1445 / 1445 | 99% | 46.57 | 181 / 183 |
pancreas | 100% | 6739.46 | 328 / 328 | 99% | 38.63 | 176 / 178 |
intestine | 100% | 4275.62 | 966 / 966 | 99% | 37.93 | 521 / 527 |
uterus | 100% | 3825.06 | 170 / 170 | 99% | 51.41 | 453 / 459 |
liver | 100% | 11045.55 | 226 / 226 | 98% | 39.77 | 399 / 406 |
breast | 100% | 3785.69 | 457 / 459 | 98% | 36.65 | 1101 / 1118 |
thymus | 100% | 3362.90 | 651 / 653 | 98% | 34.99 | 593 / 605 |
bladder | 100% | 3927.76 | 21 / 21 | 98% | 38.21 | 492 / 504 |
stomach | 98% | 4604.10 | 351 / 359 | 100% | 39.41 | 285 / 286 |
skin | 98% | 5352.40 | 1768 / 1809 | 100% | 63.88 | 470 / 472 |
prostate | 100% | 3781.58 | 244 / 245 | 97% | 25.54 | 485 / 502 |
brain | 91% | 1945.51 | 2399 / 2642 | 99% | 38.74 | 700 / 705 |
adrenal gland | 100% | 8391.66 | 258 / 258 | 87% | 28.48 | 200 / 230 |
kidney | 91% | 2782.19 | 81 / 89 | 88% | 26.86 | 796 / 901 |
muscle | 100% | 6304.36 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3022.46 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.55 | 1 / 1 |
adipose | 100% | 4712.68 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8704.80 | 1333 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 22.61 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 27.42 | 77 / 80 |
heart | 93% | 2673.81 | 798 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 4217.79 | 745 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016266 | Biological process | O-glycan processing |
GO_0018243 | Biological process | protein O-linked glycosylation via threonine |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0018242 | Biological process | protein O-linked glycosylation via serine |
GO_0051604 | Biological process | protein maturation |
GO_0005795 | Cellular component | Golgi stack |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030145 | Molecular function | manganese ion binding |
GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | GALNT2 |
Protein name | Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase) Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] |
Synonyms | GalNAc-T2 |
Description | FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Has a broad spectrum of substrates for peptides such as EA2, Muc5AC, Muc1a, Muc1b. Probably involved in O-linked glycosylation of the immunoglobulin A1 (IgA1) hinge region. Involved in O-linked glycosylation of APOC-III, ANGPTL3 and PLTP. It participates in the regulation of HDL-C metabolism . . |
Accessions | ENST00000366672.5 [Q10471-1] Q10471 A0A1L7NY41 A0A1L7NY50 |